| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
166 |
148 |
$617K |
| J0485 |
Injection, belatacept, 1 mg |
1,583 |
718 |
$529K |
| J2357 |
Injection, omalizumab, 5 mg |
789 |
454 |
$454K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
292 |
188 |
$192K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,753 |
2,607 |
$105K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,402 |
1,225 |
$81K |
| J0897 |
Injection, denosumab, 1 mg |
138 |
128 |
$48K |
| 96415 |
|
1,213 |
1,069 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,290 |
1,649 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
1,268 |
1,073 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,883 |
1,614 |
$557.29 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
16 |
13 |
$140.99 |